Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Montelukast Sodium NDC 59651-329 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure1 - montelukast fig1

Figure1 - montelukast fig1

The graph shows the change in height in centimeters over a period of 56 weeks for three different groups: a group taking Montelukast 5 mg (120 participants), a group taking Beclomethasone 336 mg (119 participants), and a group taking a placebo (121 participants). The x-axis represents the weeks on treatment and the y-axis represents the change in height in centimeters. However, the standard errors of the treatment group means in change in height are too small to be visible on the graph.*

Figure2 - montelukast fig2

Figure2 - montelukast fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (Packet) - montelukast fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (Packet) - montelukast fig3

This appears to be a combination of random and fragmented text that doesn't provide any coherent information or context. Hence, the text is not-available for generating a useful description.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 Packet Carton) - montelukast fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 Packet Carton) - montelukast fig4

Chemical Structure - montelukast str

Chemical Structure - montelukast str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.